Home › Funds › VESTOR CAPITAL, LLC › ABT

VESTOR CAPITAL, LLC position in ABT

ABBOTT LABORATORIES · Health Care

VESTOR CAPITAL, LLC reported holding 1,062,221 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$52.9M, representing 3.36% of its reported portfolio and ranking #9 among its reported holdings. VESTOR CAPITAL, LLC has disclosed ABT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.06M sh
Reported value held$52.87M
Portfolio Weight3.36%
First reportedQ3 2023
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VESTOR CAPITAL, LLC's ABT position evolved

VESTOR CAPITAL, LLC first disclosed a stake in ABT in Q3 2023 at 78,271 shares (US$7.6M). The position peaked in Q2 2025 at 151,696 shares, worth US$75.5M. Across 12 filings, VESTOR CAPITAL, LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,062,221 shares valued at US$52.9M. Notable position changes include a 109% increase in Q2 2025 (shares fell 1% over the following quarter), a 443% increase in Q4 2025 (shares fell 18% over the following quarter), a 82% trim in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 78.27K $7.58M New
Q4 2023 78.54K $8.64M Hold
Q1 2024 77.23K $8.78M Reduce
Q2 2024 75.00K $7.79M Reduce
Q3 2024 74.33K $8.47M Reduce
Q4 2024 73.89K $8.36M Reduce
Q1 2025 72.70K $9.64M Reduce
Q2 2025 151.70K $75.45M Add
Q3 2025 73.07K $9.79M Reduce
Q4 2025 396.99K $17.77M Add
Q1 2026 73.16K $7.51M Reduce
Q3 2026 1.06M $52.87M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has VESTOR CAPITAL, LLC held ABT?

VESTOR CAPITAL, LLC has disclosed ABT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is VESTOR CAPITAL, LLC's current position in ABT?

As of Q3 2026, VESTOR CAPITAL, LLC holds 1.06M shares of ABT (ABBOTT LABORATORIES), valued at $52.87M, representing 3.36% of its reported portfolio and ranking #9.

Has VESTOR CAPITAL, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), VESTOR CAPITAL, LLC newly opened its position in ABT. The position peaked in Q2 2025 at 151.70K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.